Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Change in Account Payables (2016 - 2025)

Historic Change in Account Payables for Traws Pharma (TRAW) over the last 14 years, with Q3 2025 value amounting to $524000.0.

  • Traws Pharma's Change in Account Payables rose 17464.39% to $524000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.3 million, marking a year-over-year decrease of 23846.15%. This contributed to the annual value of $646000.0 for FY2024, which is 6327.46% down from last year.
  • Per Traws Pharma's latest filing, its Change in Account Payables stood at $524000.0 for Q3 2025, which was up 17464.39% from -$3.0 million recorded in Q2 2025.
  • In the past 5 years, Traws Pharma's Change in Account Payables registered a high of $1.1 million during Q3 2023, and its lowest value of -$3.0 million during Q2 2025.
  • For the 5-year period, Traws Pharma's Change in Account Payables averaged around -$86789.5, with its median value being $100000.0 (2022).
  • Per our database at Business Quant, Traws Pharma's Change in Account Payables plummeted by 86022.73% in 2021 and then skyrocketed by 41541.67% in 2022.
  • Over the past 5 years, Traws Pharma's Change in Account Payables (Quarter) stood at -$1.3 million in 2021, then surged by 107.73% to $100000.0 in 2022, then tumbled by 629.0% to -$529000.0 in 2023, then soared by 249.91% to $793000.0 in 2024, then plummeted by 33.92% to $524000.0 in 2025.
  • Its Change in Account Payables stands at $524000.0 for Q3 2025, versus -$3.0 million for Q2 2025 and -$605000.0 for Q1 2025.